Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare News Netherlands.
CBD Wine Market is Expected to Progress at a CAGR of 21.1% to Reach US$ 371.7 Million by 2035
EIN Presswire
·
June 27, 2025
CBD Wine Market to Hit USD 371.7 Million by 2035, Driven by Wellness Trends, Legal Progress, and Demand for Non-Alcoholic, Functional Beverages. ROCKVILLE, MD, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- The global CBD wine market is...
[Latest] Global Recycled Ocean Plastics Market Size/Share Worth USD 3.50 Billion by 2034 at a 6.81% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
·
July 15, 2025
Austin, TX, USA, July 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Recycled Ocean Plastic Market Size, Trends and Insights By Source (Bottles, Fibers, Foams, Others), By Polymer Type (Polyethylene...
Surge of Preventative Healthcare Driving Nutraceuticals Market at 9.50% CAGR by 2031
EIN Presswire
·
August 9, 2024
WESTFORD, MASSACHUSETTS, UNITED STATES, August 9, 2024 /EINPresswire.com/ -- Nutraceuticals Market size was valued at USD 383.69 billion in 2022 and is poised to grow from USD 420.14 billion in 2023 to USD 868.38 billion by 2031, growing at a...
Silicone Release Coatings Market Size Worth US$ 1,787.6 Million with 7.7% CAGR by 2035: Fact.MR Report
EIN Presswire
·
July 15, 2025
Silicone Release Coatings Market set to grow steadily, driven by rising demand in labels, tapes, and industrial applications across global markets. ROCKVILLE, MD, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- The global silicone release...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
·
August 2, 2024
NAARDEN, The Netherlands and MIAMI, Aug. 02, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
Hair Extensions Market Anticipated to Hit $6.3 Billion by 2031, Annually Expand at 8.2% CAGR
EIN Presswire
·
July 15, 2025
The global hair extensions market size was valued at $2.9 billion in 2021, is projected to reach $6.3 billion by 2031, grow at a CAGR of 8.2% from 2022-2031. WILMINGTON, NEW CASTLE, DE, UNITED STATES, July 15, 2025 /EINPresswire.com/ --...
Pet Insurance Market Next Big Thing | Major Giants- Embrace, Pumpkin, Healthy Paws
EIN Presswire
·
August 21, 2024
Stay up to date with Pet Insurance Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. PUNE, MAHARASHTRA, INDIA, August 21, 2024 /EINPresswire.com/ -- According to HTF Market...
$3.2+ Billion Worldwide Athleisure Market Grow at CAGR of 5.2% from 2023 to 2032 : Rise in Health and Wellness Trends
EIN Presswire
·
August 22, 2024
The Athleisure Market Size was valued at $2 billion in 2022, and is estimated to reach $3.2 billion by 2032, growing at a CAGR of 5.2% from 2023 to 2032. WILMINGTON, DELAWARE , UNITED STATES, August 22, 2024 /EINPresswire.com/ -- Athleisure...
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
GlobeNewswire, Inc.
·
August 7, 2024
-- Reported positive topline data from pivotal Phase 3 BROOKLYN trial evaluating obicetrapib in patients with HeFH; achieved primary endpoint of LS mean reduction in LDL-C versus placebo, as well as statistically significant reductions in other...
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
GlobeNewswire, Inc.
·
July 31, 2024
VALENCIA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it...
Food Enzymes Market to Hit $3.1 billion by 2026 | Key Companies Included - DuPont (US), DSM (Netherlands), Novozymes (US), Kerry Group (Ireland) & Others
GlobeNewswire, Inc.
·
August 20, 2024
Chicago, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The food enzymes market size is estimated to be valued at USD 2.2 billion in 2021 and is projected to reach USD 3.1 billion by 2026, recording a CAGR of 6.4%, in terms of value. The growing demand for...
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024
GlobeNewswire, Inc.
·
July 26, 2024
PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders will host an investor webcast on Monday,...
NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024
GlobeNewswire, Inc.
·
July 26, 2024
NAARDEN, the Netherlands and MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
MetAlert Continues to Expand Distribution with New SmartSole Distributor in Mexico and Trials being Conducted in Spain, Portugal and Netherlands
GlobeNewswire, Inc.
·
August 15, 2024
LOS ANGELES, CALIFORNIA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT) (“the Company”), a pioneer in GPS wearable technology and a global provider in the field of human and asset tracking and recovery systems, announced today it has...
CervoMed Announces Presentation at AAIC 2024 on Plasma Biomarker Data That Are Consistent with Neflamapimod Impacting the Underlying Disease Process in Patients with Dementia with Lewy bodies (DLB)
GlobeNewswire, Inc.
·
July 29, 2024
- Baseline data from the AscenD-LB Phase 2a trial in DLB demonstrated that plasma glial fibrillary acidic protein (GFAP) was highly correlated to scores on the CDR-SB; plasma GFAP shown to increase with neurodegenerative progression in DLB – -...
Aircraft collides in UK
MENAFN
·
July 14, 2025
(MENAFN) A Beechcraft B200 aircraft crashed in Essex, UK, shortly after departing from London Southend Airport around 4:00 p.m. local time on Sunday. The crash was captured on video and widely shared on social media. Footage shows thick black...
NeuroCluster Announces AI Datacenter Platform with 5-Minute Deployment Capability
EIN Presswire
·
June 6, 2025
Dutch technology company's integrated platform reduces AI infrastructure setup time by 99% while maintaining European data residency. EINDHOVEN, NETHERLANDS, June 6, 2025 /EINPresswire.com/ -- NEUROCLUSTER today announced the general...
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
GlobeNewswire, Inc.
·
July 30, 2024
Presentation to highlight statistically significant Phase 3 results of Tonmya™ for the management of fibromyalgia, including improvement in pain and sleep quality Tonix granted FDA Fast Track Designation for Tonmya™; NDA submission on track for...
National Expansion of Functional & Integrative Dietitian Telehealth Team Covered by Insurance
GlobeNewswire, Inc.
·
July 25, 2024
Camillus, July 25, 2024 (GLOBE NEWSWIRE) -- Camillus, New York - Sarah Lynn Nutrition (SLN) is excited to announce the continued growth of its national Functional & Integrative Dietitian Telehealth team. SLN exists to Empower people to improve...
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
GlobeNewswire, Inc.
·
July 29, 2024
-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at day 84 with statistically significant reduction (p<0.0001), which was sustained at day 365 (p<0.0001) -- -- Obicetrapib lowered...